Gujarat Inject (Kerala) Ltd
₹119.00▲ +4.30 (+3.75%)
GUJINJECLTD·NSE·Healthcare
Market Cap
148.64 Cr
PE Ratio
1700.00
Volume
55,999
Day High - Low
120.40 - 117.00
52W High-Low
120.40 - 63.75
₹119.00▲ +4.30 (+3.75%)
Market Cap148.64 Cr
PE Ratio1700.00
Volume55,999
Day High - Low120.40 - 117.00
52W High-Low120.40 - 63.75
Gujarat Inject (Kerala) Ltd (GUJINJECLTD): company summary
Gujarat Inject (Kerala) Ltd (GUJINJECLTD) is a micro-cap Healthcare company valued at ₹149 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
Gujarat Inject (Kerala) Ltd (GUJINJECLTD) is a micro-cap Healthcare company valued at ₹149 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
- Recent price move
- Gujarat Inject (Kerala) Ltd last traded at ₹119, up 3.75% on the day.
- Financial performance
- Revenue has been growing strongly at 497.8% a year over three years; profit grew 256.4% a year, behind revenue — margins are under pressure. Return on equity is 16.6%.
- Valuation multiples
- The stock trades at 1700.0 times earnings, a premium to the Healthcare median of 32.0, 12.68 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Last traded ₹119.00 on 12 Jun 2026 (127 days ago). Not a live price.
DocStoX Score
5.3/10
Weak
Fair Value
Sign in to see
ROE
16.60%
Strong
P/E
1700.00x
Expensive
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals & Biotechnology
Overall View
Mixed
Price performance
Day₹117.00
₹120.40
52W₹63.75
₹120.40
DocStoX take
Supported by growth (8.5) and momentum (7.5), but held back by valuation (0.0). Growth looks strong at 8.5, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence5.3
/10
Weak
Quality
Solid
ROE 16.6%
Valuation
Expensive
P/E 200.0×
Growth
Strong
Revenue +415.3% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Strong
98% of 52-week range
At a glance
Market Cap
₹149 Cr
52W High / Low
₹120 / ₹64
Dividend Yield
0.00%
Promoter Holding
0.00%
EPS (TTM)
₹0.07
Book Value
₹0.81
Key highlights
- Revenue compounding 415% a year
- Profit compounding 256% a year
- Low leverage — D/E 0.00
- Valuation is weak (0.0/10)
- Expensive at 200× earnings
3 Positives3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals & Biotechnology
Explore Gujarat Inject (Kerala) Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Gujarat Inject (Kerala) Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Gujarat Inject (Kerala) Ltd with peers
Gujarat Inject (Kerala) Ltd vs Sun Pharmaceutical Industries LimitedGujarat Inject (Kerala) Ltd vs Divi's Laboratories LimitedGujarat Inject (Kerala) Ltd vs Torrent Pharmaceuticals LimitedGujarat Inject (Kerala) Ltd vs Apollo Hospitals Enterprise LimitedGujarat Inject (Kerala) Ltd vs Zydus Lifesciences LimitedGujarat Inject (Kerala) Ltd vs Laurus Labs Limited
Related tools & concepts
Value Gujarat Inject (Kerala) Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing